|
|
|
See related Fluad Pre-filled syringe information
|
|
| Influenza vaccine, surface antigen, inactivated, adjuvanted w/ MF59C.1 |
| Active immunisation against influenza in elderly ≥65 yr, esp for those w/ increased risk of associated complications (ie patients affected by underlying chronic diseases including diabetes, CVS & resp diseases). |
| 0.5 mL as a single dose to be administered IM into the deltoid muscle. |
| Hypersensitivity to egg or chicken proteins, aminoglycosides, formaldehyde, cetyltrimethylammonium Br, polysorbate 80. Postpone immunisation in febrile illness or acute infection. Childn & elderly patients on warfarin. |
| Do not administer SC or intravascularly. Ab response in patients w/ endogenous or iatrogenic immunosuppression may be insufficient. |
| Commonly, local inj site reactions eg redness, swelling, pain, ecchymosis, induration; fever, malaise, shivering, fatigue, headache, sweating, myalgia, arthralgia. Uncommonly, generalised skin reactions eg pruritus, urticaria or nonspecific rash. Rarely, neuralgia, paraesthesia, convulsions, transient thrombocytopenia, allergic reactions rarely leading to shock. Very rarely, vasculitis w/ transient renal involvement, exudative erythema multiforme, encephalomyelitis, neuritis, Guillain-Barre syndrome.
View
ADR Monitoring Form |
| Immunosuppressants.
View
more drug interactions with Fluad |
| | Category C: Either studies in animals have
revealed adverse effects on the foetus (teratogenic or embryocidal or
other) and there are no controlled studies in women or studies in women and
animals are not available. Drugs should be given only if the potential benefit
justifies the potential risk to the foetus.
|
|
|
View
Fluad description
for details of the chemical structure and excipients (inactive components).
|
| Vaccines, Antisera & Immunologicals |
| J07BB02 -
Influenza, purified antigen ;
Belongs to the class of influenza viral vaccines. |
| POM |
|
| Manufacturer: | Novartis Vaccines
| | Distributor: | Novartis
|
| 
| |
|
|
|